title: Iloprost in dermatology.
abstract: Rheologically active pharmacotherapy is of high importance in many dermato-logical diseases. The intravenous administration of iloprost belongs to the most effective systemic therapeutic agents that serve this pharmacodynamic approach and additionally substantial knowledge on the safety and efficacy exists. We review the dermatologically relevant data in order to offer an easy, thematically focused overview to practicing dermatologists.
authors.affiliation: Department of Dermatology and Venereology, University of Halle-Wittenberg, Halle (Saale), Germany. johannes.wohlrab@medizin.uni-halle.de
authors.forename: Johannes
authors.initials: J
authors.lastname: Wohlrab
authors.forename: Stefan
authors.initials: S
authors.lastname: Schanz
authors.forename: Jens
authors.initials: J
authors.lastname: Ulrich
mesh_terms: D003880:Dermatology / Q000639:trends*; D006801:Humans; D016285:Iloprost / Q000009:adverse effects* / Q000627:therapeutic use*; D010975:Platelet Aggregation Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D012871:Skin Diseases / Q000188:drug therapy*
chemical_list: D010975:Platelet Aggregation Inhibitors; D016285:Iloprost